Regen BioPharma Inc (RGBP)
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Regen BioPharma, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 1.68B shares outstanding
USRegen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States.
It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions.
Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
Leadership
David Raymond Koos
Chairman, Chief Executive Officer, President, Acting Chief Financial Officer, Secretary & Treasurer
Employees
1
Country
US
Sector
Healthcare
Website
regenbiopharmainc.com
based on 1.68B shares outstanding
US30d Avg
3.27M
60d Avg
4.85M
90d Avg
8.36M